InvestSMART

Paradigm Biopharmaceuticals Limited (ASX: PAR) - Announcements

- Current share price for PAR : $0.245

ASX company news and announcements for Paradigm Biopharmaceuticals Limited (PAR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Paradigm Biopharmaceuticals Limited (PAR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Paradigm Biopharmaceuticals Limited (PAR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Paradigm Biopharmaceuticals Limited (PAR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$153 September 2025 Quarterly Activities Report & Appendix 4C 30 Oct 2025 9:38AM $0.425 $0.245 fallen by 42.35%
$153 Notice of Annual General Meeting/Proxy Form 20 Oct 2025 2:22PM $0.400 $0.245 fallen by 38.75%
$153 Application for quotation of securities - PAR 8 Oct 2025 2:55PM $0.375 $0.245 fallen by 34.67%
$153 Phase 3 Knee OA Trial Recruiting and Dosing in AUS & US 30 Sep 2025 10:46AM $0.310 $0.245 fallen by 20.97%
$153 Results of Meeting 23 Sep 2025 2:43PM $0.290 $0.245 fallen by 15.52%
$153 DATE OF AGM AND CLOSING DATE FOR DIRECTOR NOMINATIONS 22 Sep 2025 5:41PM $0.285 $0.245 fallen by 14.04%
$153 Unmarketable Parcel Sale Facility 11 Sep 2025 12:02PM $0.265 $0.245 fallen by 7.55%
$153 Application for quotation of securities - PAR 9 Sep 2025 2:48PM $0.263 $0.245 fallen by 6.67%
$153 Evans and Partners Healthcare Conference Presentation 9 Sep 2025 9:06AM $0.275 $0.245 fallen by 10.91%
$153 Appendix 4G and Corporate Governance Statement 29 Aug 2025 1:44PM $0.280 $0.245 fallen by 12.50%
$153 Appendix 4E and 2025 Annual Report 29 Aug 2025 1:32PM $0.280 $0.245 fallen by 12.50%
$153 Paradigm Launches InvestorHub 28 Aug 2025 9:37AM $0.290 $0.245 fallen by 15.52%
$153 Application for quotation of securities - PAR 25 Aug 2025 5:29PM $0.295 $0.245 fallen by 16.95%
$153 Notice of Extraordinary General Meeting/Proxy Form 22 Aug 2025 12:47PM $0.303 $0.245 fallen by 19.01%
$153 Investor Webinar Presentation 31 Jul 2025 8:56AM $0.385 $0.245 fallen by 36.36%
$153 June 2025 Quarterly Activities Report & Appendix 4C 29 Jul 2025 9:26AM $0.400 $0.245 fallen by 38.75%
$153 Paradigm Investor Webinar 24 Jul 2025 9:22AM $0.430 $0.245 fallen by 43.02%
$153 Application for quotation of securities - PAR 22 Jul 2025 2:57PM $0.420 $0.245 fallen by 41.67%
$153 Notice under Section 708A 7 Jul 2025 4:03PM $0.435 $0.245 fallen by 43.68%
$153 Notification regarding unquoted securities - PAR 7 Jul 2025 2:49PM $0.435 $0.245 fallen by 43.68%
$153 Notice under Section 708A 2 Jul 2025 12:59PM $0.375 $0.245 fallen by 34.67%
$153 Application for quotation of securities - PAR 2 Jul 2025 12:52PM $0.375 $0.245 fallen by 34.67%
$153 Proposed issue of securities - PAR 1 Jul 2025 8:54AM $0.305 $0.245 fallen by 19.67%
$153 Proposed issue of securities - PAR 1 Jul 2025 8:39AM $0.305 $0.245 fallen by 19.67%
$153 Paradigm Secures US$27M to Advance Phase 3 OA Trial 1 Jul 2025 8:31AM $0.305 $0.245 fallen by 19.67%

101 - 125 of 743 results

Page 5 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.